Radiation literature survey

The radiation literature survey provides updates on published literature related to radiation (both ionising and non-ionising) and health.

Published literature includes articles in peer-reviewed scientific journals, scientific-body reports, conference proceedings, etc.

The updates on new radiation literature that are of high quality and of public interest will be published as they arise. For each update, a short summary and a link to the abstract or to the full document (if freely available) are provided. The update may also include a commentary from ARPANSA and links to external websites for further information. The links may be considered useful at the time of preparation of the update however ARPANSA has no control over the content or currency of information on external links. Please see the ARPANSA website disclaimer.

Explanations of the more common terms used in the updates are found in the glossary.

The radiation literature that is listed in the updates is found by searching various databases and is not exhaustive.

Find out more about how you can search for scientific literature.

The intention of the radiation literature survey is to provide an update on new literature related to radiation and health that may be of interest to the general public. ARPANSA does not take responsibility for any of the content in the scientific literature and is not able to provide copies of the papers that are listed.


Are you looking for earlier editions of the Radiation literature survey?

Visit the National Library of Australia Australian Government Web Archive to access archived information no longer available on our website.

European survey on laser safety management in medical settings

Article publication date

March 2026

Article review date

7 September 2026

Summary

This article reports on a survey undertaken amongst the European Federation of Organisations for Medical Physics (EFOMP) national member organisations to examine existing regulatory frameworks, organisational practices, training arrangements, and safety oversight related to medical application of laser (Light Amplification by Stimulated Emission of Radiation). The survey was conducted during 2024-2025 and received 25 responses from member organisations. It focussed on regulatory aspects, organisational practices, the role of medical physicists in managing laser sources, quality assurance and laser safety as well as training. The findings show variability in laser safety governance, expertise, and implementation across participating countries. The survey found that medical physicists commonly contributed to laser safety oversight, health risk management, quality assurance, and the optimisation of medical laser applications. More than half of the respondents indicated that dedicated laser safety roles were inadequate or absent, potentially compromising day-to-day laser safety compliance in medical settings. Nearly half also reported a lack of formal processes for reporting laser-related incidents and insufficient laser safety documentation. Many countries reported that laser safety training was primarily delivered through in-house programs offered by healthcare organisations and training provided by equipment manufacturers. The survey also found a lack of structured and independent laser safety training programs. The findings indicate that the standard of medical laser safety practice varies considerably across European countries. The authors emphasise the need for a more consistent and harmonised approach to laser safety in healthcare to minimise potential risks to both patients and workers.

Published in

Physica Medica

Link to

European survey on laser safety management in medical settings

ARPANSA commentary

This survey was conducted against a backdrop of increasing global adoption of medical lasers in hospitals and clinics as well as lasers increasingly being used for cosmetic purposes. The findings highlight opportunities to strengthen laser safety practices through greater standardisation of regulations, training and qualification of laser safety experts, incident reporting systems and safety documentation. Consistent and evidence-based safety programs remain important for protecting both patients and workers. Although based on a limited number of countries, the survey provides valuable insights into current medical laser safety practices in Europe. However, the findings may not be fully generalisable to other settings. In Australia, lasers are widely used in healthcare, cosmetic and beauty therapy sectors. The medical use of lasers in Australia is regulated by the Therapeutic Goods Administration. For cosmetic use regulation varies across jurisdictions; QLD, WA and TAS regulate certain laser applications under radiation safety legislation, while NSW, VIC, SA, ACT and NT have limited or no licensing requirements (Karipidis et al, 2023). There is limited information (Smalley, 2011) on the adequacy of laser safety, existing education or training on laser safety in the Australian healthcare sector.  ARPANSA and Monash University researchers (Thomas et al., 2026) have found health injuries following cosmetic laser treatments in Australia indicating inadequate laser safety compliance and regulatory gaps. ARPANSA provides evidence-based advice on laser safety for consumers and users in the cosmetic industry, helping to raise awareness of potential health risks. International Commission on Non-Ionizing Radiation Protection recommends exposure limits to protect the eyes and skin from laser radiation (ICNIRP, 2013). ICNIRP has also published a statement on the cosmetic use of lasers as well as other non-ionising radiation sources (ICNIRP, 2020). Since medical lasers can exceed these limits during normal operation, appropriate safety controls and protective eyewear are essential to protect workers and patients.

 

Korean study indicates a modest association between maternal mobile phone use during early childhood and child behavioural problems

Article publication date

15 September 2026

Article review date

17 November 2026

Summary

This prospective cohort study investigated whether maternal mobile phone use during pregnancy or during a child's early years was associated with behavioural problems in preschool-aged children. Data from the Korean Mothers and Children's cohort (n=780 mother-child pairs) were used to estimate maternal mobile phone use (self-reported daily call duration) during pregnancy and when the child was aged 3, 4, and 5 years. A range of children's behavioural outcomes including attention, aggressive behaviour, anxiousness, were evaluated at ages 4, 5 and 6 years. Associations between maternal phone use and behavioural outcomes in children were estimated using regression coefficients (β) with 95% confidence intervals (CI), following the adjustment for potential confounders. Maternal mobile phone use during early childhood was associated with higher total behavioural problem scores (β=1.37; 95% CI: 0.46–2.28) and externalising problem scores (β = 1.44; 95% CI: 0.54–2.33), whereas prenatal use was not. The study concluded that maternal mobile phone use during a child's early years, rather than during pregnancy, may be associated with behavioural problems in preschool-aged children. The authors suggest that the observed associations could be due to mobile phone use practice (rather than radiofrequency electromagnetic field (RF-EMF) exposure from mobile phones), which disrupts mother-child interaction or caregiving pathways.

Published in

Environmental Research

Link to

Maternal mobile phone use during pregnancy versus early childhood in relation to behavioral problems in preschool-aged children: A prospective cohort study

ARPANSA commentary

These findings are broadly consistent with the current evidence, such as a World Health Organization review lead by Australian researchers and other studies across the world (e.g., Ajmal et al., 2023) including from Australia (Bhatt et al., 2017; Thomas et al., 2011). These studies, together with the current study, does not provide convincing evidence that low-level maternal RF-EMF exposure from mobile phone use during pregnancy adversely affects cognitive development in children. The adoption of a prospective design and assessment of mobile phone use during both pregnancy and early childhood are notable strengths of the study. However, the study also has several limitations. First, the study did not explore how the phone was used (i.e., speaker phone, headphones or held to the ear), which largely determines to what extent mothers could have been exposed to RF-EMF and its potential impact on children’s behaviour outcomes. Second, self-reported call duration only serves as a crude a proxy for RF-EMF exposure in mothers (Benke et al., 2024). Third, it did not account for potential residual confounding such as children's screen time or digital media use, maternal medication use and maternal physical activity.

Based on the current scientific evidence, and consistent with the findings of this study, it is the assessment of ARPANSA that there is no substantiated evidence that maternal mobile phone use during pregnancy and early childhood (resulting in RF-EMF exposures at levels below the limits set in the ARPANSA Safety Standard) cause any adverse health effects, including behavioural outcomes in children. 

No changes in blood for healthcare workers exposed to ionising radiation

Article publication date

27 August 2026

Article review date

16 November 2026

Summary

This epidemiological study examined blood parameters among healthcare workers exposed to ionising radiation while administering fluoroscopically-guided medical imaging procedures. Routine occupational health surveillance records from 136 exposed and 272 matched unexposed healthcare workers collected throughout their employment were examined. Blood parameters were assessed prior to any exposure at the beginning of their employment and again when occupational exposure ceased or the follow-up period of the study concluded. The strength of the exposure was assessed by dose records from mandated personal dosimeters.

The average annual dose was 0.22 mSv over an average follow-up time of 18.9 years. There was no statistically significant difference between exposed and unexposed groups for any measured blood parameter. There was also no difference when comparing exposed healthcare workers with cumulative exposure greater than 3 mSv to those with less than 3 mSv accumulated exposure. Similarly, participants who were exposed for greater than 10 years did not show any statistically significant difference in blood parameters to participants exposed for less than 10 years. 

Published in

Epidemiologia

Link to

Hematological Parameters and Occupational Ionizing Radiation Exposure in Interventional Healthcare Workers: A Longitudinal Matched Case-Control Study

ARPANSA commentary

The most studied health endpoints related to ionising radiation exposure are those relating to well-established risks like cancer (US NRC, 2006). Given the clear ethical barriers that the established cancer risks present, studies on the relationship between low-dose exposure and other health endpoints are difficult to conduct experimentally and so observational studies, when well conducted, are best suited for generating evidence for the risks surrounding those endpoints.

An error that deserves clarification is that the article has incorrectly identified its study design as a case-control study in several sections including the title. Case-control studies identify participants who have a condition, in this case irregular blood parameters, and compare exposure among participants that have the condition (the cases) and those that don’t (the controls). The article more correctly identifies the study design as a retrospective cohort study in the methods section, although it is still unclear if the cohort was established correctly for this study design.

The Code of Practice for Radiation Protection in Planned Exposure Situations (2020) RPS C-1 describes limits for exposure to ionising radiation for occupationally exposed persons as well as provisions for monitoring the exposures those persons receive as was done for the exposed participants in this study. Together with the Safety Guide for Radiation Protection in Diagnostic and Interventional Radiology (2008) and the Safety Guide for Radiation Protection in Nuclear Medicine (2008), these documents provide information for healthcare workers administering interventional imaging procedures to safely manage their exposure. This is important as the amount of these procedures is rising (AIHW, 2025). Annual doses recorded in this study are far below occupational exposure limits prescribed in RPS-C1 and also below doses that are recorded for many other exposed occupations (ANRDR, 2025).

Solar ultraviolet radiation trending up in Europe

Article publication date

12 August 2026

Article review date

10 October 2026

Summary

This study collated and assessed data from 40 ultraviolet (UV) radiation monitoring stations in Europe. This data was analysed for trends in daily UV dose between 2013 and 2022. All stations demonstrated a trend for increasing UV exposure ranging between 0.46% per year to 2.6% per year. For 26 of these stations, this trend was statistically significant and this represents an increase in the total daily radiant exposure of approximately one standard erythemal dose (SED) every 5 years for these stations.

Data from these ground UV monitoring stations was corroborated by satellite observations which mapped increases in surface solar radiant exposure commensurate with the locations and magnitudes of the ground monitoring station observations. Analysis of monthly data revealed that these increases were more widespread and more severe in particular months, rather than consistent throughout the year.

Measurements of ozone in the atmosphere from satellites showed that there were no trends or changes that would account for the observed changes in daily UV exposure. However, increases in average sunshine duration, measured by satellite or by a monitoring station on the ground, showed a correlation with the corresponding increases in daily UV exposure. The increase in average daily sunshine duration was primarily driven by reductions in cloud cover.

Published in

Photochemical & Photobiological Sciences

Link to

Recent increases in solar UV radiation across Europe: a 40-location study to identify trend boundaries 

ARPANSA commentary

This study highlights the importance of measuring UV radiation for informing sun protection practices and identifying trends in exposure that are relevant to public health. The ground monitoring stations in the study were particularly important for alpine sites as there were frequent discrepancies between satellite and ground data for those sites. In the Australian context that reinforces the importance of ARPANSA’s UV monitoring network for identifying longitudinal trends in addition to daily use. While a similar type of analysis on UV index trends has not been conducted for Australia, the data from the monitoring network could facilitate such analysis. A nuance that deserves clarification is that this study did not report increases in maximal UV intensity on clear sky days but reported on total UV exposure, which aligns with attributing the increases to changes in cloud cover rather than atmospheric ozone concentration. Studies that have assessed changes in UV exposure in Australia have used clear sky models that do not take into account cloud cover (Lemus-Deschamps, L., 2011).

It is important to note that both the UV intensity, and total UV exposure in Australia substantially exceeds that of most of the European sites examined in this study. That is reflected in the incidence and mortality data for skin cancers (De Pinto, G., 2024; AIHW, 2025) in Australia as exposure to UV radiation accounts for the overwhelming majority of skin cancers (Olsen, C., 2015; Armstrong & Kricker, 2001). That exposure can be effectively managed by following the five sun protection principles whenever the UV index is over three: Slip, Slop, Slap, Seek and Slide.

UK Biobank study shows no association between mobile phone use and brain cancer

Article publication date

14 July 2026

Article review date

29 September 2026

Summary

This prospective cohort study investigated the link between mobile phone use and types of brain tumour, including glioma, glioblastoma, meningioma and acoustic neuroma. It included 467,801 participants aged 40–69 years from the UK Biobank prospective cohort. Participants were originally recruited between 2006-2010 and followed up till 2023. During the 13-year follow-up period, 1,607 brain tumours were identified in the cohort. Participants who had been regular mobile phone users for more than 8 years at recruitment were compared with participants who had never been regular users. No association between mobile phone use and brain tumour was found (Hazard ratio (HR): 0.93, 95% confidence interval (CI): 0.79-1.08). No association with brain tumour was observed among participants reporting the highest weekly call time (>6 hours) (HR: 0.75, 95 % CI: 0.47-1.21) or with any brain tumour type including glioma (HR: 0.78, 95% CI: 0.49-1.24), meningioma (HR: 0.85, 95% CI: 0.46-1.57) or acoustic neuroma (HR: 0.52, 95 % CI: 0.10-2.56). The authors concluded that mobile phone use is not associated with an increased risk of brain tumours. 

Published in

SSRN

Link to

Mobile phone use and brain tumour risk: Evidence from the UK Biobank Cohort

ARPANSA commentary

The results are similar to a previous UK Biobank (Zhang et al., 2024) analysis, as well as other large cohort studies like the Danish Cohort Study (Frei et al., 2011) and the Million Women Study (Schüz et al., 2022) and COSMOS Study (Feychting et al., 2024) that all found no association between mobile phone use and brain cancer.  

The strength of this UK Biobank study is the prospective nature of the study, and it adds to the literature by conducting a more detailed categorisation of self-reported mobile phone than previous studies (Schüz et al., 2022) to better identify the most exposed users. The self-reported data is an improvement over the Danish Cohort Study (Frei et al., 2011) that only demined exposure based on mobile phone subscriptions which is more prone to exposure misclassification. The COSMOS Study (Feychting et al., 2024) partly addresses this limitation through the use of operator phone usage data in addition to self-reported information. However, neither this or the COSMOS study collected mobile phone use data after baseline recruitment and both studies don’t incorporate the change in mobile phone use over time including and the introduction of the smart phone. Consequently, the weekly call times reported at baseline may not accurately reflect the participants’ mobile phone use during the follow-up period. 

Development of an internationally adaptable public education on ultraviolet radiation protection for fair-skinned populations

Article publication date

April 2026

ARPANSA review date

24 August 2026

Summary

This paper describes the development of a public education leaflet with an aim to improve the effectiveness and dissemination of ultraviolet radiation (UVR) protection messages. Recognising that skin cancer incidence remains high and continues to increase in many fair-skinned populations despite longstanding public awareness campaigns, the authors sought to create a clear, scientifically accurate, and internationally adaptable communication resource. The leaflet was developed according to health promotion and public education guidelines and underwent multiple rounds of expert and stakeholder review, including input from patient and non-government organisations as well as specialists in dermato-oncology, epidemiology and public health. The final resource promotes avoiding intentional sun exposure and tanning while positioning the use of shade and protective clothing as highest priority for sun protection. It also includes advice on childhood sun protection, the risks associated with tanning beds, early detection of skin cancer, vitamin D considerations, and sunscreen safety. The article concludes that educational interventions should be complemented by policy and environmental measures, such as increased provision of public shade and regulation of tanning facilities. The article recommends that the leaflet is made available in multiple languages and distributed via professional and online channels. 

Published in

Journal of the European Academy of Dermatology and Venereology

Link to article:

Messages for ultraviolet-radiation protection to fair-skinned populations

ARPANSA commentary

The article reinforces the importance of sustained, evidence-based communication strategies for UVR protection. Australia provides a strong example of the potential impact of such efforts, with decades of public education and awareness campaigns contributing to the stabilisation and reduction of skin cancer incidence rates in some populations (De Pinto et al., 2024) despite the country continuing to experience one of the highest UV exposure levels globally. Over the past four decades, a number of stakeholders including Cancer Council Australia, the Skin Cancer College Australasia, and Melanoma Institute Australia have led extensive public education and awareness campaigns promoting sun protection behaviours to reduce harmful UV exposure. The findings of this paper should therefore be considered within the context of Australia's well-established skin cancer prevention framework. The paper highlights that sun protection measures should commence when the UV Index is 3 or above, which aligns with ARPANSA’s advice. ARPANSA advises the use of all five sun protection measures to minimise personal UVR exposure: Slip, Slop, Slap, Seek and Slide. ARPANSA also provides real-time UV Index information and estimates of UVR dose to help inform the public on daily UVR exposure and support them in making informed decisions regarding their sun protection. This is important as Australia faces a significant public health burden from UVR-related skin cancer. 

Review on radiofrequency electromagnetic fields and pregnancy outcomes misses the mark

Article publication date

20 March 2026

ARPANSA review date

August 2026

Summary

This review discusses the potential impact on pregnancy outcomes of radiofrequency electromagnetic field (RF-EMF) exposure from mobile phone use during pregnancy. The authors report conducting a literature review of studies published between 2015 and 2024, including human epidemiological, animal, in vitro and review articles. The results of the literature search were not presented. Similarly, although the authors stated that study quality was assessed using the Newcastle-Ottawa Scale and SYRCLE Risk of Bias tool, the outcomes of these assessments were not reported. The authors discuss approximately 22 studies and conclude that the evidence remains limited and inconclusive. However, they further stated that precautionary measures to reduce mobile phone exposure during pregnancy may be warranted. 

Link to article

Impact of mobile phone use during pregnancy on fetal development and birth defects: a review

Published in

Annals of Clinical and Analytical Medicine

ARPANSA commentary

This is a poor narrative review of the evidence into RF-EMF and pregnancy outcomes. Although the authors mention that a systematic search and study quality assessment were conducted, the results of these are not presented. Further, the authors only assessed papers published after 2015, unless papers were highly cited (mentioned in other papers) and there is no justification for the selection of this timeframe nor defined criteria for high citation. Despite the wide inclusion criteria, only 22 studies are cited and discussed in the article. Repeating just one search term on one search engine already returns far more articles that meet the review’s inclusion criteria than are acknowledged in the paper. Also, there are studies cited in an inconsistent referencing format that do not appear in the reference list at all which means it is not possible to evaluate the source of the information the review uses to form its conclusions.

The review places substantial weight on a disparate mixture of animal and in vitro studies while giving limited consideration to the consistency and quality of the human epidemiological evidence. The articles that are cited, are done so in support of statements that are unrelated to the content of the cited article. For example, an article on ionising radiation exposure (Mainprize et al., 2023) is cited in relation to congenital abnormalities and maternal mobile phone use despite mobile phone use never being mentioned by Mainprize et al. 

The evidence on the effects of RF-EMF exposure on pregnancy outcomes has recently been evaluated in World Health Organization-supported systematic reviews and meta-analyses, including one assessing adverse pregnancy outcomes in human epidemiological studies (Johnson et al., 2024) and a second assessing experimental animal study (Cordelli et al., 2023). These reviews applied state-of-the-art systematic review methods to evaluate whether maternal RF-EMF exposure is associated with adverse pregnancy outcomes. The review of human studies concluded that, in both the general and occupational populations, the available evidence generally does not support an association between RF-EMF exposure and adverse pregnancy outcomes; however, the evidence is very uncertain due to variability in the results and methodological limitations. Similarly, the animal systematic review did not identify consistent evidence that RF-EMF exposure adversely affects pregnancy outcomes. It is difficult to understand why one of these reviews was cited in the article but not the other. 

The scientific evidence is in line with the public health messaging of ARPANSA that exposure to RF-EMF below the limits in the ARPANSA RF Standard (RPS-S1) does not impact people’s health.

 

Survey of Sydney's natural background radiation confirms it is similarly low to global levels

Article publication date

February 2026

ARPANSA review date

August 2026

Summary

This study provides the first terrestrial gamma-radiation map of Sydney city and establishes baseline natural background radiation levels across the region. The study, conducted in 2025, measured terrestrial and cosmic gamma radiation levels across the land and sea. The study primarily used a low-cost portable gamma detector. Soil samples were also collected from 26 locations (mostly public parks) in Sydney. The soil samples were used to estimate (using high purity Germanium detectors) the activity concentration (Bq/kg) of naturally occurring radionuclides (Uranium-238 (238U), Thorium-232 (232Th) and Potassium-40 (40K). Finally, annual effective doses(mSv/year) from outdoor natural background radiation were estimated. Average terrestrial and cosmic gamma doses were found to be 0.24 mSv/year and 0.17 mSv/year, respectively. The mean soil activities reported were: 29 Bq∕kg (232Th), 19 Bq∕kg (238U), and 179 Bq∕kg (40K). Geological composition, such as lithology and radionuclide content, of the soil/rock in the region was identified as the primary factor influencing the spatial distribution of background radiation and reported doses across the city. This study confirms that the radionuclides in soil/rock and background radiation doses in Sydney are consistent and within the range of typical global values. 

Article published in

Journal of Environmental Radioactivity

Link to study

Sydney’s first terrestrial gamma-radiation map

ARPANSA commentary

This study offers a valuable means of communicating that ionising radiation is a natural part of our everyday environment, occurring as background radiation and presenting no significant risk to the public. The activity concentrations of the radionuclides in this study are well correlated with local geology; 238U and 40K concentrations in particular, which are slightly lower than the previously reported Australian or global average values  (UNSCEAR, 2024 p. 77). The lower concentration of naturally occurring radionuclides explains the lower reported year-long terrestrial outdoor dose rate (0.24 mSv/y) when compared to the global average (0.3 mSv/y) (UNSCEAR 2024). The reported year-long outdoor cosmic dose (0.17 mSv/y) is nearly half the global average (0.33 mSv/y) and that reported for Australia in a previous study (0.35 mSv/y) (Tate et al., 2021). This discrepancy is likely due to the sensitivity of the detector to cosmic radiation.  The total average annual dose, combining terrestrial and cosmic components, has been estimated to be 3 mSv globally (UNSCEAR, 2024). Of this, total external terrestrial radiation dose is 0.4 mSv and total inhalation dose is 1.8 mSv. The later dose is mainly constituted by radon (222Rn) and decay products originating from 238U decay. Notably, the current study did not report on internal radiation doses resulting from the inhalation and ingestion of radionuclides (e.g., radon), which generally constitute a major contribution to the total public dose from natural radiation sources. 

The Australian Radiation Protection and Nuclear Safety Agency’s Environmental Radiation Monitoring System maintains a network of automated ambient gamma detectors in Lucas Heights (NSW), Yallambie (VIC), Darwin (NT) and Joondalup (WA) to continuously monitor background radiation and evaluate exposure trends. Over the past four decades, Geoscience Australia and the State and Northern Territory Geological Surveys have collected gamma-ray spectrometric data (through airborne surveys using low flying aeroplanes/helicopters) across the majority of Australia. Collectively, the Australian public is provided relevant information about the levels of naturally occurring radionuclides and expected radiation exposure in our environment. In Australia, the Code for Radiation Protection in Existing Exposure Situations  sets out the requirements for the protection of the public and the environment in existing exposure situations.  

Human experiments and modelling techniques combine to determine the level that magnetic field exposure can be felt

Article review date

7 August 2026

Article publication date

27 July 2026

ARPANSA summary

This study combined advances in anatomical modelling and data from human experiments to calculate the induced electric field in human tissues from low frequency magnetic field exposure at the threshold of perception (the level where a person can feel a slight tingling on the skin). The arms of 24 subjects were positioned into a magnetic stimulation device. Participants were in control of the level of the applied stimulation and adjusted the level themselves until it was just barely perceptible, which was marked as the threshold level.

Images captured during testing were used to combine the participants’ forearms with highly featured anatomical forearm models generated from magnetic resonance images. The matched models were then used to compute the induced electric field in the participant’s forearm at the threshold of perception. The calculated average perception threshold was at an induced electric field of 32.2 V/m, with variability between subjects of 5.2 V/m.

The anatomical modelling methodology used in this study was also compared to simpler methodologies used in prior research. The authors found that the simpler methodologies underestimate the induced electric field at the perception threshold and they subsequently used this information to develop a correction coefficient (an adjustment value) for values from earlier research. 

Published in

Bioelectromagnetics

Link to article

Evaluating Human Perception Thresholds in Magnetic Stimulation Using Experimental Measurements and Modelling

ARPANSA commentary

This study is a significant advancement in the computational methods used to determine the induced electric field in tissues at the threshold of perception in humans. In addition to increased model sophistication, a notable difference between this study and previous studies is the method used to arrive at the perception threshold. In prior research (Saritas, E. et al., 2013; Havel, W. et al., 1997), experimenters controlled the stimulus level in pre-defined steps. Allowing participants to repeatedly adjust the exposure level as in this study may lead to more accurately determined thresholds but simultaneously introduces additional psychological confounders; for example, the stimulation device would make a noise which may have made the subjects think that they perceived the exposure. A major limitation, as acknowledged by the authors, is that the forearm models used in the study did not include detailed nerve architecture, offering an avenue for further improvement in future studies.

It is important to note that exposures of the level used in this study do not occur in the everyday environment. ARPANSA has measured extremely low frequency magnetic field (ELF-EMF) exposure in Australian homes (Karipidis, K., 2014) and near electrical supply infrastructure (technical report 170). In both measurement surveys, levels were far below the limits prescribed in international guidelines and farther below the exposure used in this study. 

The International Commission on Non-Ionizing Radiation Protection is currently reviewing its low frequency exposure guidelines. Studies like this one will help to inform the development of these guidelines. The limits prescribed in the exposure guidelines are set conservatively, with consideration for uncertainty in the scientific evidence and are ultimately far below the level at which adverse health effects are known to occur. 

DNA damage from the sun occurs even without sunburn

Article publication date

29 June 2026

ARPANSA review date

30 July 2026

Summary

This experimental study on human subjects examined if low doses of ultraviolet (UV) radiation produce adverse effects in skin. 58 pale-skin participants (Fitzpatrick type I-III) were exposed to UV radiation doses of 0.7 and 1.6 standard erythemal doses (SED) at 3 locations for each dose on their back. A biopsy of the exposed area was taken 15 minutes after exposure along with a biopsy of an unexposed control area. The remaining exposure sites were biopsied at 24 and 72 hours after the first exposure, with UV exposure repeating at 24 and 48 hours. Additionally, the participants were divided into two groups according to the rate at which the doses were applied, either at UV index 2.8 or UV index 8.0, to investigate whether the intensity at which a dose is applied has an impact. 

UV exposure caused an increase in DNA damage at all time points, with the higher dose group exhibiting more DNA damage than the lower dose group. Tumour supressing gene expression was increased in the biopsy taken after 24 and 72 hours, but not at 15 minutes. The higher dose group again exhibited greater increases than the lower dose group. A small non-statistically significant increase in oxidative stress was measured for each dose group. The UV index used to apply the dose did not affect any of the endpoints measured.

Published in

Photochemistry and Photobiology

Link to article

The burning question: Does exposure to low dose and low irradiance ultraviolet radiation lead to cutaneous DNA damage in people with skin types I–III?

ARPANSA summary

The study found that low doses of UV radiation cause DNA damage in humans and an increase in the amount of tumour-suppressing genes. This is because the amount of DNA damage was proportional to the UV dose, which is in agreement with other studies conducted in humans (Tewari, A. et al., 2012; Olsen, C. et al., 2017; Katiyar, S. et al., 2007). However, the short-term nature of the study means it was not designed to assess the long-term consequences of UV-induced DNA damage at low doses, including its potential effects on tumour development or growth. 

The doses used in this study were chosen to reflect doses that have been estimated to maintain adequate vitamin D when exposed four times per week (Elliot, M. et al., 2023; Neale, R. et al., 2024). This is a challenging area of sun protection as consideration must be given to balancing the risks and benefits of sun exposure. The Australian Skin and Skin Cancer Research Centre has published a joint position statement on balancing these factors. However, many Australians are routinely exposed to UV doses that far exceed those used in this experiment (Australian Bureau of Statistics, 2024), a fact that is reflected in the very high incidence and mortality of skin cancer in Australians (De Pinto, G. et al., 2024).

This study showed that direct DNA damage happens even when a sunburn does not occur, underscoring the need to use all five sun protection measures whenever the UV index is over three: slip, slop, slap, seek and slide. In the context of this study where a UV index below three was used for some participants, it is important to note that DNA damage can happen at high or low UV index values, provided a person is exposed for a long enough time to accrue the same total UV dose. In relation to the above sun protection advice, this means that even when the UV index is below three, sun protection should be used if in the sun for a prolonged time period, as an unprotected person can accrue a substantial UV dose in those circumstances.

Access to information FOI disclosure log Information public scheme